IDEXX Labs (IDXX) Tops Q4 EPS by 13c, issues 2023 guidance
Get Alerts IDXX Hot Sheet
Price: $560.38 -1.13%
EPS Growth %: +15.5%
Financial Fact:
Cost of product revenue: 103.91M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +15.5%
Financial Fact:
Cost of product revenue: 103.91M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $2.05, $0.13 better than the analyst estimate of $1.92. Revenue for the quarter came in at $829 million versus the consensus estimate of $820.91 million.
GUIDANCE:
IDEXX Labs sees FY2023 EPS of $9.27-$9.75, versus the consensus of $9.51. IDEXX Labs sees FY2023 revenue of $3.590-3.690 billion, versus the consensus of $3.619 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- BioNTech and Bristol Myers Squibb report Phase 2 data for pumitamig in NSCLC
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share